Fecal microbiota transplantation for diseases: Therapeutic potential, methodology, risk management in clinical practice.

[1]  J. Walter,et al.  Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial , 2021, Nature Medicine.

[2]  A. Kaltsas,et al.  Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy , 2021, Digestive Diseases and Sciences.

[3]  W. D. de Vos,et al.  Fecal microbiota transplantation in human metabolic diseases: From a murky past to a bright future? , 2021, Cell metabolism.

[4]  E. Hsiao,et al.  SnapShot: The microbiota-gut-brain axis , 2021, Cell.

[5]  Hong Wei,et al.  Fecal Microbiome Transplantation from Children with Autism Spectrum Disorder Modulates Tryptophan and Serotonergic Synapse Metabolism and Induces Altered Behaviors in Germ-Free Mice , 2021, mSystems.

[6]  Gongying Li,et al.  Fecal microbiota transplantation ameliorates stress-induced depression-like behaviors associated with the inhibition of glial and NLRP3 inflammasome in rat brain. , 2021, Journal of psychiatric research.

[7]  Wei Chen,et al.  Crosstalk between sIgA-Coated Bacteria in Infant Gut and Early-Life Health. , 2021, Trends in microbiology.

[8]  J. Badger,et al.  Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients , 2021, Science.

[9]  A. Puel,et al.  Human gut mycobiota tune immunity via CARD9-dependent induction of anti-fungal IgG antibodies , 2021, Cell.

[10]  K. Hashimoto,et al.  A role of the subdiaphragmatic vagus nerve in depression-like phenotypes in mice after fecal microbiota transplantation from Chrna7 knock-out mice with depression-like phenotypes , 2021, Brain, Behavior, and Immunity.

[11]  T. Vatanen,et al.  Strain engraftment competition and functional augmentation in a multi-donor fecal microbiota transplantation trial for obesity , 2020, Microbiome.

[12]  N. Ajami,et al.  Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients , 2020, Science.

[13]  Lijun Shen,et al.  Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study , 2020, Clinical Cancer Research.

[14]  K. Clément,et al.  Gut microbiota-derived metabolites as central regulators in metabolic disorders , 2020, Gut.

[15]  T. Vatanen,et al.  Effects of Fecal Microbiome Transfer in Adolescents With Obesity , 2020, JAMA network open.

[16]  Yu Fang,et al.  Prebiotics‐Encapsulated Probiotic Spores Regulate Gut Microbiota and Suppress Colon Cancer , 2020, Advanced materials.

[17]  R. Knight,et al.  Fecal Microbiota Transplant is Highly Effective in Real-World Practice: Initial Results from the FMT National Registry. , 2020, Gastroenterology.

[18]  T. Hibi,et al.  Ulcerative colitis , 2020, Nature Reviews Disease Primers.

[19]  E. Hsiao,et al.  The maternal microbiome modulates fetal neurodevelopment in mice , 2020, Nature.

[20]  T. Vatanen,et al.  Linking strain engraftment in fecal microbiota transplantation with maintenance of remission in Crohn's disease. , 2020, Gastroenterology.

[21]  F. Hu,et al.  Effects of Diet-Modulated Autologous Fecal Microbiota Transplantation on Weight Regain. , 2020, Gastroenterology.

[22]  A. Khoruts,et al.  Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology , 2020, Nature Reviews Gastroenterology & Hepatology.

[23]  B. Blom,et al.  Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients , 2020, Science Translational Medicine.

[24]  Zhang Faming.  Nanjing consensus on methodology of washed microbiota transplantation , 2020, Chinese medical journal.

[25]  A. Grakoui,et al.  Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. , 2020, Gastroenterology.

[26]  Yaping Tian,et al.  Pilot study of cytokine changes evaluation after fecal microbiota transplantation in patients with ulcerative colitis. , 2020, International immunopharmacology.

[27]  Yong Guo,et al.  The gut microbiota attenuates muscle wasting by regulating energy metabolism in chemotherapy-induced malnutrition rats , 2020, Cancer Chemotherapy and Pharmacology.

[28]  E. Diamandis,et al.  Drug-Resistant Bacteremia after Fecal Microbiota Transplant. , 2020, The New England journal of medicine.

[29]  M. Abreu,et al.  Candida in IBD: Friend or Foe? , 2020, Cell Host and Microbe.

[30]  J. Clemente,et al.  Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative Colitis. , 2020, Cell host & microbe.

[31]  Z. Zeng,et al.  Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract , 2020, Frontiers in Immunology.

[32]  H. Tilg,et al.  Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel , 2020, The Lancet Gastroenterology & Hepatology.

[33]  C. Kelly,et al.  Risk Factors that Predict the Failure of Multiple Fecal Microbiota Transplantations for Clostridioides difficile Infection , 2020, Digestive Diseases and Sciences.

[34]  D. Ramai,et al.  Fecal Microbiota Transplantation (FMT) with Colonoscopy Is Superior to Enema and Nasogastric Tube While Comparable to Capsule for the Treatment of Recurrent Clostridioides difficile Infection: A Systematic Review and Meta-Analysis , 2020, Digestive Diseases and Sciences.

[35]  P. Carlson.  Regulatory Considerations for Fecal Microbiota Transplantation Products. , 2020, Cell host & microbe.

[36]  M. Kamm,et al.  Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice , 2020, Gut.

[37]  K. Clément,et al.  Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity? , 2020, Gastroenterology.

[38]  H. Sokol,et al.  Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study , 2020, Microbiome.

[39]  Keith K. Fenrich,et al.  Fecal transplant prevents gut dysbiosis and anxiety-like behaviour after spinal cord injury in rats , 2020, PloS one.

[40]  Johnson J. Liu,et al.  Fecal microbiota transplantation improves metabolism and gut microbiome composition in db/db mice , 2020, Acta Pharmacologica Sinica.

[41]  Bota Cui,et al.  Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening , 2020, Protein & Cell.

[42]  E. Svoboda.  Could the gut microbiome be linked to autism? , 2020, Nature.

[43]  C. Manichanh,et al.  Mucosal microbial load in Crohn's disease: A potential predictor of response to faecal microbiota transplantation , 2020, EBioMedicine.

[44]  A. Sood,et al.  Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study) , 2020, Journal of gastroenterology and hepatology.

[45]  T. Borody,et al.  Oral fecal microbiota transplant for recurrent Clostridium difficile in pediatric autoimmune enteropathy. , 2019, European journal of gastroenterology & hepatology.

[46]  M. Jiang,et al.  The Functional Role of Fecal Microbiota Transplantation on Dextran Sulfate Sodium-Induced Colitis in Mice , 2019, Front. Cell. Infect. Microbiol..

[47]  M. Osman,et al.  Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial , 2019, Hepatology.

[48]  C. Kelly,et al.  Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT) , 2019, Journal of clinical gastroenterology.

[49]  W. Ko,et al.  Fecal microbiota transplantation for Clostridium difficile infection in Taiwan: Establishment and implementation. , 2019, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[50]  H. Tilg,et al.  International consensus conference on stool banking for faecal microbiota transplantation in clinical practice , 2019, Gut.

[51]  Huijue Jia,et al.  Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice , 2019, Molecular Psychiatry.

[52]  C. Kelly,et al.  The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications , 2019, The Lancet.

[53]  Zhaohua Shen,et al.  Fecal Microbiota Transplant via Endoscopic Delivering Through Small Intestine and Colon: No Difference for Crohn’s Disease , 2019, Digestive Diseases and Sciences.

[54]  A. Khoruts,et al.  Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection , 2019, mBio.

[55]  Yan Zhou,et al.  Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study , 2019, BMC Gastroenterology.

[56]  K. Clément,et al.  Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes? , 2019, Current Diabetes Reports.

[57]  Irina Leonardi,et al.  Gut Mycobiota in Immunity and Inflammatory Disease. , 2019, Immunity.

[58]  Evgeni Levin,et al.  Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time , 2019, Gut.

[59]  S. Lynch,et al.  Fecal microbiota transplant for Crohn disease: A study evaluating safety, efficacy, and microbiome profile , 2019, United European gastroenterology journal.

[60]  J. Caporaso,et al.  Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota , 2019, Scientific Reports.

[61]  J. Clemente,et al.  Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis. , 2019, Gastroenterology.

[62]  J. Jovel,et al.  The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study , 2019, Gut microbes.

[63]  Thomas B. Clarke,et al.  Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection , 2019, Gut.

[64]  R. Bryant,et al.  Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty , 2019, Internal medicine journal.

[65]  E. Kuijper,et al.  Clinical Application and Potential of Fecal Microbiota Transplantation. , 2019, Annual review of medicine.

[66]  F. Carbonnel,et al.  Effectiveness and Safety of Reference Infliximab and Biosimilar in Crohn Disease: A French Equivalence Study , 2018, Annals of Internal Medicine.

[67]  Huiping Xu,et al.  Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[68]  R. Kalla,et al.  The Role of Autologous Fecal Microbiota Transplantation in Diversion Colitis: A Case Report. , 2018, Inflammatory bowel diseases.

[69]  Bota Cui,et al.  Fecal microbiota transplantation relieve painful diabetic neuropathy , 2018, Medicine.

[70]  F. Ryan,et al.  Long-term colonisation with donor bacteriophages following successful faecal microbial transplantation , 2018, Microbiome.

[71]  B. Helmink,et al.  Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis , 2018, Nature Medicine.

[72]  Leaf Huang,et al.  Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis , 2018, Advanced materials.

[73]  Yang‐Yu Liu,et al.  Timing for the second fecal microbiota transplantation to maintain the long-term benefit from the first treatment for Crohn’s disease , 2018, Applied Microbiology and Biotechnology.

[74]  Bota Cui,et al.  The Safety of Fecal Microbiota Transplantation for Crohn’s Disease: Findings from A Long-Term Study , 2018, Advances in Therapy.

[75]  D. Wishart,et al.  Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. , 2018, American journal of physiology. Endocrinology and metabolism.

[76]  V. Young,et al.  Restoration of short chain fatty acid and bile acid metabolism following fecal microbiota transplantation in patients with recurrent Clostridium difficile infection. , 2018, Anaerobe.

[77]  Anthony M. Haag,et al.  Antibiotic‐Associated Disruption of Microbiota Composition and Function in Cirrhosis Is Restored by Fecal Transplant , 2018, Hepatology.

[78]  H. Williams,et al.  Introduction to the joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) faecal microbiota transplant guidelines. , 2018, Journal of Hospital Infection.

[79]  Jun Yu,et al.  Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection , 2018, Nature Communications.

[80]  F. Shanahan,et al.  Changes in microbiota composition, bile and fatty acid metabolism, in successful faecal microbiota transplantation for Clostridioides difficile infection , 2018, BMC Gastroenterology.

[81]  O. Fiehn,et al.  Gut microbial and metabolomic profiles after fecal microbiota transplantation in pediatric ulcerative colitis patients. , 2018, FEMS microbiology ecology.

[82]  A. Lusis,et al.  Host Genetic Background and Gut Microbiota Contribute to Differential Metabolic Responses to High Fructose Consumption in Mice , 2018, bioRxiv.

[83]  Xiao-Zhi Zheng,et al.  Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies , 2018, Journal of Crohn's & colitis.

[84]  C. Manichanh,et al.  Restoration of a healthy intestinal microbiota normalizes portal hypertension in a rat model of nonalcoholic steatohepatitis , 2018, Hepatology.

[85]  D. Suskind,et al.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients. , 2018, Journal of the Pediatric Infectious Diseases Society.

[86]  A. Goyal,et al.  Safety, Clinical Response, and Microbiome Findings Following Fecal Microbiota Transplant in Children With Inflammatory Bowel Disease. , 2018, Inflammatory bowel diseases.

[87]  Laurence Zitvogel,et al.  Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors , 2018, Science.

[88]  W. Petritsch,et al.  The taxonomic composition of the donor intestinal microbiota is a major factor influencing the efficacy of faecal microbiota transplantation in therapy refractory ulcerative colitis , 2017, Alimentary pharmacology & therapeutics.

[89]  Jun Yu,et al.  Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome , 2017, Gut.

[90]  D. Brumbaugh,et al.  An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive , 2017, The Journal of pediatrics.

[91]  S. Taylor-Robinson,et al.  Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial , 2017, Hepatology.

[92]  O. Inatomi,et al.  Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case series. , 2017, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[93]  Lu Zheng,et al.  Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction , 2017, World journal of gastroenterology.

[94]  J. G. Mitchell,et al.  Faecal microbiota transplantation donor stools need screening for poliovirus , 2017, Gut.

[95]  Evgeni Levin,et al.  Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition. , 2017, Cell metabolism.

[96]  N. Bhala,et al.  Systematic review with meta‐analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection , 2017, Alimentary pharmacology & therapeutics.

[97]  Arjun Gupta,et al.  Fecal Microbiota Transplantation. , 2017, JAMA.

[98]  Sophie J. Weiss,et al.  Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease , 2017, Microbiome.

[99]  E. Zoetendal,et al.  Microbial shifts and signatures of long-term remission in ulcerative colitis after faecal microbiota transplantation , 2017, The ISME Journal.

[100]  D. Ciocan,et al.  Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice. , 2017, Journal of hepatology.

[101]  M. Kamm,et al.  Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis , 2017, Journal of Crohn's & colitis.

[102]  N. Ajami,et al.  Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection – fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy , 2017, Alimentary pharmacology & therapeutics.

[103]  Thierry Hennet,et al.  Mechanisms and consequences of intestinal dysbiosis , 2017, Cellular and Molecular Life Sciences.

[104]  M. Kamm,et al.  Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial , 2017, The Lancet.

[105]  S. Schreiber,et al.  Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection. , 2017, Gastroenterology.

[106]  Junling Zhang,et al.  Faecal microbiota transplantation protects against radiation‐induced toxicity , 2017, EMBO molecular medicine.

[107]  S. Lerouge,et al.  Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis. , 2017, Acta biomaterialia.

[108]  S. Lynch,et al.  The Human Intestinal Microbiome in Health and Disease. , 2016, The New England journal of medicine.

[109]  M. Tang,et al.  Fecal microbial transplantation in a pediatric case of recurrent Clostridium difficile infection and specific antibody deficiency , 2016, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

[110]  W. D. de Vos,et al.  Long-term effects on luminal and mucosal microbiota and commonly acquired taxa in faecal microbiota transplantation for recurrent Clostridium difficile infection , 2016, BMC Medicine.

[111]  M. Mellow,et al.  Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease , 2016, Inflammatory bowel diseases.

[112]  A. Khoruts,et al.  Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection. , 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[113]  M. Lerch,et al.  Fecal Microbiota Transplant in Patients With Recurrent Clostridium Difficile Infection. , 2016, Deutsches Arzteblatt international.

[114]  M. Gershon,et al.  The bowel and beyond: the enteric nervous system in neurological disorders , 2016, Nature Reviews Gastroenterology &Hepatology.

[115]  M. Oh-Park,et al.  Peripheral Neuropathy After Fecal Microbiota Transplantation for Clostridium difficile Infection: A Case Report , 2016, PM & R : the journal of injury, function, and rehabilitation.

[116]  John T. Chang,et al.  The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium , 2016, The American Journal of Gastroenterology.

[117]  M. Wilcox,et al.  Clostridium difficile infection: epidemiology, diagnosis and understanding transmission , 2016, Nature Reviews Gastroenterology &Hepatology.

[118]  Ron Milo,et al.  Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans , 2016, Cell.

[119]  P. Tandon,et al.  Fecal microbiota transplantation in the management of hepatic encephalopathy , 2016, Hepatology.

[120]  Jason B. Williams,et al.  Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy , 2015, Science.

[121]  Hongwei Gao,et al.  Fecal microbiota transplantation and bacterial consortium transplantation have comparable effects on the re-establishment of mucosal barrier function in mice with intestinal dysbiosis , 2015, Front. Microbiol..

[122]  E. Zoetendal,et al.  Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis. , 2015, Gastroenterology.

[123]  M. Surette,et al.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial. , 2015, Gastroenterology.

[124]  M. Ramesh,et al.  Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma , 2015, Bone Marrow Transplantation.

[125]  Chih-Jung Chang,et al.  Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota , 2015, Nature Communications.

[126]  Sophie J. Weiss,et al.  Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection , 2015, Microbiome.

[127]  Samuel I. Miller,et al.  Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn's Disease , 2015, Inflammatory bowel diseases.

[128]  Chris Sander,et al.  Precision microbiome restoration of bile acid-mediated resistance to Clostridium difficile , 2014, Nature.

[129]  G. Russell,et al.  Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. , 2014, JAMA.

[130]  J. Bartlett,et al.  Efficacy of combined jejunal and colonic fecal microbiota transplantation for recurrent Clostridium difficile Infection. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[131]  M. Mellow,et al.  Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients , 2014, The American Journal of Gastroenterology.

[132]  A. Khoruts,et al.  Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[133]  Raffaella Casadei,et al.  An estimation of the number of cells in the human body , 2013, Annals of human biology.

[134]  Lee M. Kaplan,et al.  Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity , 2013, Science Translational Medicine.

[135]  E. Zoetendal,et al.  Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. , 2012, Gastroenterology.

[136]  E. Kuijper,et al.  Clostridium difficile infection in HIV-seropositive individuals and transplant recipients. , 2012, The Journal of infection.

[137]  L. Brandt,et al.  Should We Standardize the 1,700-Year-Old Fecal Microbiota Transplantation? , 2012, The American Journal of Gastroenterology.

[138]  Jeffrey I. Gordon,et al.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice , 2007, Proceedings of the National Academy of Sciences.

[139]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[140]  Ting Wang,et al.  The gut microbiota as an environmental factor that regulates fat storage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.